Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23077737 | 0.86 | PPARG (0.41) | F2MEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL23074711 | 0.85 | MEN1 (0.52) | MEN1KMT2AALDH1A1NPSR1GAA | |
| SCHEMBL23074715 | 0.84 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL23074644 | 0.84 | KDM4E (0.51) | MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL23074687 | 0.81 | SLC6A9 (0.42) | ALDH1A1 | |
| SCHEMBL23074691 | 0.79 | SLC6A9 (0.35) | MEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL23074671 | 0.77 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL23074674 | 0.75 | HRH3 (0.47) | MEN1KMT2AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL22831325 | 0.75 | KCNH2 (0.53) | MEN1KMT2AALDH1A1TP53ALOX15 | |
| SCHEMBL23074697 | 0.74 | HTR2A (0.47) | MEN1KMT2AALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | BIO-RAD LABORATORIES, INC. | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | ABCG2, SLC7A1, MSR1 | F2 984/4885MEN1 3364/4885KMT2A 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.